The peptide has a relatively short half-life of approximately 20 minutes, meaning it clears the body quickly while stimulating growth hormone release that lasts much longer
Dinh Tran, MD , at Family Health Care
3.1% placebo (N=2,539) Key mechanism / GLP-1 agonists slow gastric emptying, suppress glucagon, and activate satiety centers in the hypothalamus Inference label / Any claim linking Clarkson to a specific molecule is inference, not confirmed fact What Kelly Clarkson Has Actually Said About Weight-Loss Medication Kelly Clarkson's own words are the only reliable starting point here
The drug was already approved earlier this year for obesity and overweight with related conditions, effectively expanding the company's total addressable market with the addition of an oral alternative to injectable GLP-1 drugs.
This is particularly relevant for patients who have not achieved adequate lipid control with statins alone